Urogen Pharma Ltd. · NASDAQ:URGN
Schoenberg Mark sold 60,677 Urogen Pharma Ltd. shares (Form 4)
Traded Aug 20, 2026 · Filed Aug 24, 2026
On Aug 20, 2026, Schoenberg Mark (Chief Medical Officer) sold 60,677 Urogen Pharma Ltd. shares at US$47.05 for US$2.85M, leaving 59,086 shares. Filed Aug 24, 2026 (Form 4).
- Sold
- 60,677 shares
- Price
- US$47.05
- Value
- US$2.85M
- Holding after
- 59,086 shares
- Trading plan
- No
- Role
- Chief Medical Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Aug 20, 2026 | ordinary shares | Sale | 60,677 | US$47.05 | 59,086 | Direct |
Source
Related
- Urogen Pharma Ltd.
- Schoenberg Mark
- Urogen Pharma Ltd. shareholders
- Form 4 · Schoenberg Mark · Sep 9, 2026
- Form 4 · Schoenberg Mark · Jul 10, 2026
- Form 4 · Schoenberg Mark · Jun 24, 2026
- Form 4 · Schoenberg Mark · Jun 9, 2026
- Form 4 · Schoenberg Mark · May 11, 2026
- Form 4 · Degnan Chris · Oct 9, 2026
- Form 4 · Smith Jason Drew · Sep 9, 2026
- Form 4 · Robinson James A. Jr. · Aug 28, 2026
- Form 4 · Robinson James A. Jr. · May 27, 2026